Aviva’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $491K | Buy |
3,575
+319
| +10% | +$43.9K | ﹤0.01% | 746 |
|
|
2025
Q1 | $587K | Buy |
+3,256
| New | +$587K | ﹤0.01% | 728 |
|
|
2021
Q2 | – | Sell |
-17,198
| Closed | -$1.33M | – | 923 |
|
|
2021
Q1 | $1.33M | Sell |
17,198
-11,896
| -41% | -$917K | 0.01% | 745 |
|
|
2020
Q4 | $1.75M | Sell |
29,094
-23,584
| -45% | -$1.42M | 0.01% | 709 |
|
|
2020
Q3 | $2.27M | Sell |
52,678
-2,621
| -5% | -$113K | 0.01% | 714 |
|
|
2020
Q2 | $2.29M | Sell |
55,299
-37,644
| -41% | -$1.56M | 0.01% | 704 |
|
|
2020
Q1 | $4.02M | Buy |
+92,943
| New | +$4.02M | 0.03% | 461 |
|